| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0017 | 1 |